# Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

> **NCT06025396** · PHASE1 · COMPLETED · sponsor: **Tempero Bio, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Cocaine Use Disorder
- Substance Use Disorders
- Healthy Volunteers

## Interventions

- **DRUG:** Cohort 1 - TMP-301
- **DRUG:** Placebo
- **DRUG:** Cohort 2 - TMP-301
- **DRUG:** Cohort 3 - TMP-301
- **DRUG:** Cohort 4 - TMP-301

## Key facts

- **NCT ID:** NCT06025396
- **Lead sponsor:** Tempero Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-06
- **Primary completion:** 2023-12-22
- **Final completion:** 2024-01-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06025396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06025396, "Multiple Ascending Dose Study of TMP-301 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06025396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*